Michael Lee Brooks - Dec 16, 2021 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role
Chief Development Officer, Clinical Solutions
Signature
/s/ Sara Epstein, Attorney-in-Fact
Stock symbol
SYNH
Transactions as of
Dec 16, 2021
Transactions value $
-$59,637
Form type
4
Date filed
12/20/2021, 04:10 PM
Previous filing
Nov 5, 2021
Next filing
Dec 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Tax liability -$59.6K -603 -6.33% $98.90 8.92K Dec 16, 2021 By spouse
holding SYNH Class A Common Stock 33K Dec 16, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Development Officer, Clinical Solutions